Mardi Dier is SVP and CFO of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 6,914 shares of MDGL, which is worth approximately $2.4 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 1,961 shares (Common Stock) at a price of $324.72 per share, resulting in proceeds of $636,775. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.91K
n/a 3M change
n/a 12M change
Total Value Held $2.4 Million

Mardi Dier Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
SELL
Open market or private sale
$636,775 $324.72 p/Share
1,961 Reduced 22.1%
6,914 Common Stock

Also insider at

RARE
Ultragenyx Pharmaceutical Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
PRLD
Prelude Therapeutics Inc Healthcare
SLRN
ACELYRIN, Inc.
MD

Mardi Dier

SVP and CFO
Novato, CA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Track Activities on MDGL